FREYR Battery (NYSE: FREY), a leading developer in clean, next-generation battery cell production, has reached a significant milestone in its operations with the successful completion of its first production trial at the Customer Qualification Plant (“CQP”) in Mo i Rana, Norway. This accomplishment marks FREYR as the first company to achieve automated production trials on…
VoltR Advances Sustainable Lithium Battery Manufacturing with €4 Million Seed Funding VoltR, a pioneering French deep-tech company specializing in sustainable lithium batteries, has successfully raised €4 million in seed funding to scale its innovative processes. The funding round, led by prominent investors including C4 Ventures, Exergon, Pays de la Loire Participations, and Anjou Amorçage, marks…
Valneva SE has achieved a historic milestone with Health Canada’s approval of the world’s first chikungunya vaccine. Following its successful launch in the U.S. and pending European authorization, this decision underscores IXCHIQ®’s pivotal role in global healthcare strategy. Chikungunya, a mosquito-borne virus causing severe joint pain and fever, poses a significant public health threat with…
In a groundbreaking move for the tech startup scene, Berlin-based mika has successfully raised €800k in pre-seed funding to bolster its mission of simplifying accounting and tax obligations for small and medium enterprises (SMEs). Led by the strategic alliance Samen Slimmer, comprising Keen Venture Partners, DFF, and Slimmer AI, this investment marks a pivotal moment…
Since its inception, Ethris GmbH has been a trailblazer in mRNA technology, revolutionizing the biotech landscape with its innovative approach to respiratory and cardiovascular diseases. Founded on a vision of harnessing messenger RNA (mRNA) for therapeutic breakthroughs, Ethris has consistently pushed boundaries, drawing attention from investors and global biotech leaders alike. Breakthroughs and Strategic Growth…
PolTREG S.A., a pioneering biotechnology firm specializing in cellular therapies for autoimmune disorders, has announced groundbreaking findings from its long-term clinical study on PTG-007, a polyclonal Treg cell therapy for early-onset type-1 diabetes (T1D). Over a span of 7 to 12 years, pediatric patients treated with PTG-007 demonstrated sustained insulin secretion, contrasting starkly with a…
Singapore-based fintech startup SoSoValue has announced the successful closure of a $4.15 million seed funding round, led by prominent investors including HongShan, GSR Markets, Alumni Ventures, CoinSummer Labs, and One Piece Labs. Noteworthy contributions also came from co-founders of leading Web3 and AI technology firms, alongside early backers of Ethereum and Gitcoin. Founded with a…
Marea Therapeutics has marked a significant milestone with the successful closure of a $190 million combined Series A and B financing, positioning the clinical-stage biotechnology firm to accelerate its pioneering efforts in cardiometabolic disease treatments. Led by Third Rock Ventures and supported by a consortium of leading investors including Sofinnova Investments, Forbion, and Perceptive Xontogeny…
In a remarkable feat of entrepreneurial spirit, high school graduates Christopher Fitzgerald and Nicholas Van Landschoot have secured a substantial $500,000 seed investment for their innovative startup, APIGen. This funding, provided by Varana Capital, marks a significant milestone for the duo as they embark on their journey into the competitive world of tech entrepreneurship. APIGen,…
In a groundbreaking move set to redefine the future of satellite connectivity, French spacetech startup Skynopy has announced a significant funding milestone. Securing $3.1 million in a recent investment round, cementing its position as a formidable player in the burgeoning space industry. The funding round saw enthusiastic participation from prominent investors including Heartcore Capital, Kima…
